Literature DB >> 7974641

[A short scale for measuring social support in the elderly: the SSL12-I].

L M van Eijk1, G I Kempen, F L van Sonderen.   

Abstract

De SSL12-I is the shortened version of Social Support List--Interaction version, and is meant to be used with elderly people. The instrument consists of three subscales: 'everyday social support', 'social support in problem situations' and 'esteem support'. Each subscale has 4 items. The SSL12-I is initially developed on the basis of a selective research sample (N = 98). The SSL12-I was now been tested in a random sample of elderly people (N = 245). The three principal components, as initially found in the selective research sample and corresponding with the three subscales, stand out even more clearly in the random sample. Internal consistency, as measured with Cronbach's alpha, is .82, .79, .75 respectively for the subscales, and .87 for the total scale. Construct validity of the SSL12-I is satisfactory.

Entities:  

Mesh:

Year:  1994        PMID: 7974641

Source DB:  PubMed          Journal:  Tijdschr Gerontol Geriatr        ISSN: 0167-9228


  20 in total

1.  Ethnic identity and the risk of schizophrenia in ethnic minorities: a case-control study.

Authors:  Wim Veling; Hans W Hoek; Durk Wiersma; Johan P Mackenbach
Journal:  Schizophr Bull       Date:  2009-05-08       Impact factor: 9.306

2.  The role of coping resources and coping style in quality of life of patients with asthma or COPD.

Authors:  A E Hesselink; B W J H Penninx; M A G Schlösser; H A H Wijnhoven; D A W M van der Windt; D M W Kriegsman; J Th M van Eijk
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

3.  Perceived discrimination and the risk of schizophrenia in ethnic minorities: a case-control study.

Authors:  Wim Veling; Hans W Hoek; Johan P Mackenbach
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-06-23       Impact factor: 4.328

Review 4.  Social networks, support and early psychosis: a systematic review.

Authors:  C Gayer-Anderson; C Morgan
Journal:  Epidemiol Psychiatr Sci       Date:  2012-07-26       Impact factor: 6.892

5.  Reasons for non-standard treatment in elderly patients with advanced head and neck cancer.

Authors:  W Derks; J R J de Leeuw; G J Hordijk; J A M Winnubst
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-03-11       Impact factor: 2.503

6.  Loneliness among women with rheumatoid arthritis: a cross-cultural study in the Netherlands and Egypt.

Authors:  Tarek M El-Mansoury; Erik Taal; Ahmed M Abdel-Nasser; Robert P Riemsma; Refaat Mahfouz; Jehan A Mahmoud; Samir A El-Badawy; Johannes J Rasker
Journal:  Clin Rheumatol       Date:  2008-04-01       Impact factor: 2.980

7.  Determinants of return to work in patients with hand disorders and hand injuries.

Authors:  Lonneke Opsteegh; Heleen A Reinders-Messelink; Donna Schollier; Johan W Groothoff; Klaas Postema; Pieter U Dijkstra; Corry K van der Sluis
Journal:  J Occup Rehabil       Date:  2009-05-13

8.  Case-finding of dementia in general practice and effects of subsequent collaborative care; design of a cluster RCT.

Authors:  Pim van den Dungen; Eric P Moll van Charante; Harm W J van Marwijk; Henriëtte E van der Horst; Peter M van de Ven; Hein P J van Hout
Journal:  BMC Public Health       Date:  2012-08-04       Impact factor: 3.295

9.  Depression and anxiety, an indicated prevention (DIP) protocol in homes for the elderly: feasibility and (cost) effectiveness of a stepped care programme.

Authors:  Els Dozeman; Digna J F van Schaik; Aartjan T F Beekman; Wim A B Stalman; Judith E Bosmans; Harm W J van Marwijk
Journal:  BMC Geriatr       Date:  2007-03-08       Impact factor: 3.921

10.  The SMILE study: a study of medical information and lifestyles in Eindhoven, the rationale and contents of a large prospective dynamic cohort study.

Authors:  Marjan van den Akker; Mark G Spigt; Lore De Raeve; Ben van Steenkiste; Job F M Metsemakers; Ernst J van Voorst; Hein de Vries
Journal:  BMC Public Health       Date:  2008-01-21       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.